High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women
Authors:
- 24 September 2010
- journal article
- other
- Published by Wolters Kluwer Health in AIDS
- Vol. 24 (15) , 2416-2418
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Pharmacokinetics and drug–drug interactions of antiretrovirals: An updateAntiviral Research, 2010
- Role of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancyJournal of Pharmaceutical Sciences, 2009
- New treatment options for HIV salvage patients: An overview of second generation PIs, NNRTIs, integrase inhibitors and CCR5 antagonistsJournal of Infection, 2008
- Inhibition of placental P‐glycoprotein: impact on indinavir transfer to the foetusBritish Journal of Clinical Pharmacology, 2007
- Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase EnzymeDrug Metabolism and Disposition, 2007
- Pregnancy-Induced Changes in PharmacokineticsClinical Pharmacokinetics, 2005
- Expression of members of the multidrug resistance protein family in human term placentaAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2000
- Glucuronidation in HumansClinical Pharmacokinetics, 1999